Professor, Department of Chemistry and Biochemistry
After earning a Ph.D. in Biochemistry and Molecular Biology from Oregon Health Sciences University, and serving as a Postdoctoral Fellow in Molecular Immunology at the Portland (OR) VA Medical Center, Dr. Ken Cornell joined the faculty of the Department of Chemistry and Biochemistry at Boise State University in 2004. Dr. Cornell's research interests include antibiotic development targeting bacterial and parasite methionine salvage, farnesol metabolism in eukaryotic cells, and development of forensic reagents. One of the primary investigations in his lab is the identification of new targets for antimicrobial drug development.
Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).
read more
Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).
×
About Kenneth Cornell
After earning a Ph.D. in Biochemistry and Molecular Biology from Oregon Health Sciences University, and serving as a Postdoctoral Fellow in Molecular Immunology at the Portland (OR) VA Medical Center, Dr. Ken Cornell joined the faculty of the Department of Chemistry and Biochemistry at Boise State University in 2004. Dr. Cornell's research interests include antibiotic development targeting bacterial and parasite methionine salvage, farnesol metabolism in eukaryotic cells, and development of forensic reagents. One of the primary investigations in his lab is the identification of new targets for antimicrobial drug development.
Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).
Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).
| Present | Professor, Boise State University ‐ Department of Chemistry and Biochemistry | |
|
|
||
Disciplines
Research Interests
Grants
| 2023 - 2026 | Acquisition of a Liquid Chromatography-High Resolution Mass Spectrometry System for Multidisciplinary Research and Training |
| National Science Foundation - 2320410 | |
| MRI: Track 1 | |
| Role: Co-Principal Investigator | |
| Colleague(s): Xinzhu Pu (PI), Julia Oxford (Co-PI), Jennifer Forbey (Co-PI), and Owen McDougal (Co-PI) | |
| $710,000 | |
| 2019 - 2022 | Exploring the challenges and opportunities of plasma jet printing for NASA's emerging In-Space Manufacturing (ISM) program |
| NASA | |
| NASA Established Program to Stimulate Competitive Research (EPSCoR) | |
| Role: Co-Investigator | |
| Colleague(s): Harish Subbaraman, David Estrada, Jim Browning, and Nirmala Kandadai | |
| $700,000 | |
| 2020 - 2020 | Continue work on engineered plasma arrays designed to remove biofilms from food processing surfaces |
| US Department of Agriculture | |
| Role: Co-Principal Investigator | |
| Colleague(s): Jim Browning | |
| $478,500 |
Honors and Awards
- 1994-1996 NIH Molecular Hematology Predoctoral Fellowship, Dept. of Hematology, Oregon Health Sciences University
- 1992 & Cell Biology Fellowship, Oregon Health Sciences University
Contact Information
phone:(208)426-5429
Email: